bibliographic entry 10330630 [be/10330630]
https://w3id.org/oc/corpus/be/10330630

is a
content
  • Van Cutsem, E, Eng, C, Nowara, E, Swieboda-Sadlej, A, Tebbutt, NC, Mitchell, E. Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer. Clin Cancer Res (2014) 20: 4240–50. DOI: 10.1158/1078-0432.CCR-13-2752 PMID: 24919569
references